BSX-Spin-out Navilyst Charts New Course
Navilyst Medical, one of several properties recently spun out of Boston Scientific, has designs on growing into a large player in the venous access and fluid management industries.
You may also be interested in...
The spate of recent carve-outs from Boston Scientific has private equity and venture capital investors hungry for similar deals across the industry. But device companies don't seem to be serving much up.
Boston Scientific, in a bid to raise capital and focus its efforts, is selling off lower priority businesses as well as its stakes in nearly 100 private and public companies.
Although oncology remained strong, Japanese major says it saw multiple impacts from the pandemic, including on hospital visits and clinical trial recruitment, and has already cut its full-year guidance.